Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 million in gross proceeds.
Additionally, Microbot Medical announced it secured definitive agreements for a registered direct offering and a concurrent private placement, raising approximately $7 million before fees and expenses.
The company will sell 4 million shares of common stock at $1.75 per share and issue short-term Series G preferred investment options to purchase up to 8 million additional shares, exercisable at the same price for two years.
H.C. Wainwright & Co. is the exclusive placement agent for the transactions, which are expected to close on or about January 7, pending customary conditions.
Proceeds will support the development and commercialization of Microbot's LIBERTY Robotic System, expand its IP portfolio applications and fund general corporate purposes.
How To Buy MBOT Stock
By now you're likely curious about how to participate in the market for Microbot Medical – be it to purchase shares, or even attempt to bet against the company.
In the the case of Microbot Medical, which is trading at $2.9 as of publishing time, $100 would buy you 34.48 shares of stock.
According to data from Benzinga Pro, MBOT has a 52-week high of $2.95 and a 52-week low of $0.82.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
